MicroRNAs as paracrine signaling mediators in cancers and metabolic diseases

Akiko Matsuda, Irene K. Yan, Catherine Foye, Mansi Parasramka, Tushar C Patel

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

The contribution of microRNAs to the regulation of mRNA expression during physiological and developmental processes are well-recognized. These roles are being expanded by recent observations that emphasize the capability of miRNA to participate in inter-cellular signaling and communication. Several factors support a functional role for miRNA as mediators of cell-to-cell signaling. miRNA are able to exist within the extracellular milieu or circulation, and their stability and integrity maintained through association with binding proteins or lipoproteins, or through encapsulation within cell-derived membrane vesicles. Furthermore, miRNA can retain functionality and regulate target gene expression following their uptake by recipient cells. In this overview, we review specific examples that will highlight the potential of miRNA to serve as paracrine signaling mediators in metabolic diseases and cancers. Elucidating the mechanisms involved in inter-cellular communication involving miRNA will provide new insights into disease pathogenesis and potential therapeutic opportunities.

Original languageEnglish (US)
Pages (from-to)577-590
Number of pages14
JournalBest Practice and Research: Clinical Endocrinology and Metabolism
Volume30
Issue number5
DOIs
StatePublished - Oct 1 2016

Fingerprint

Paracrine Communication
Metabolic Diseases
MicroRNAs
Neoplasms
Physiological Phenomena
Lipoproteins
Carrier Proteins
Cell Membrane
Gene Expression
Messenger RNA

Keywords

  • cancer microenvironment
  • cell–cell communication
  • extracellular vesicles
  • metabolic disorders
  • miRNAs

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

MicroRNAs as paracrine signaling mediators in cancers and metabolic diseases. / Matsuda, Akiko; Yan, Irene K.; Foye, Catherine; Parasramka, Mansi; Patel, Tushar C.

In: Best Practice and Research: Clinical Endocrinology and Metabolism, Vol. 30, No. 5, 01.10.2016, p. 577-590.

Research output: Contribution to journalReview article

Matsuda, Akiko ; Yan, Irene K. ; Foye, Catherine ; Parasramka, Mansi ; Patel, Tushar C. / MicroRNAs as paracrine signaling mediators in cancers and metabolic diseases. In: Best Practice and Research: Clinical Endocrinology and Metabolism. 2016 ; Vol. 30, No. 5. pp. 577-590.
@article{e695abd03f3f4647a86fd55304540d96,
title = "MicroRNAs as paracrine signaling mediators in cancers and metabolic diseases",
abstract = "The contribution of microRNAs to the regulation of mRNA expression during physiological and developmental processes are well-recognized. These roles are being expanded by recent observations that emphasize the capability of miRNA to participate in inter-cellular signaling and communication. Several factors support a functional role for miRNA as mediators of cell-to-cell signaling. miRNA are able to exist within the extracellular milieu or circulation, and their stability and integrity maintained through association with binding proteins or lipoproteins, or through encapsulation within cell-derived membrane vesicles. Furthermore, miRNA can retain functionality and regulate target gene expression following their uptake by recipient cells. In this overview, we review specific examples that will highlight the potential of miRNA to serve as paracrine signaling mediators in metabolic diseases and cancers. Elucidating the mechanisms involved in inter-cellular communication involving miRNA will provide new insights into disease pathogenesis and potential therapeutic opportunities.",
keywords = "cancer microenvironment, cell–cell communication, extracellular vesicles, metabolic disorders, miRNAs",
author = "Akiko Matsuda and Yan, {Irene K.} and Catherine Foye and Mansi Parasramka and Patel, {Tushar C}",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.beem.2016.07.005",
language = "English (US)",
volume = "30",
pages = "577--590",
journal = "Best Practice and Research in Clinical Endocrinology and Metabolism",
issn = "1521-690X",
publisher = "Bailliere Tindall Ltd",
number = "5",

}

TY - JOUR

T1 - MicroRNAs as paracrine signaling mediators in cancers and metabolic diseases

AU - Matsuda, Akiko

AU - Yan, Irene K.

AU - Foye, Catherine

AU - Parasramka, Mansi

AU - Patel, Tushar C

PY - 2016/10/1

Y1 - 2016/10/1

N2 - The contribution of microRNAs to the regulation of mRNA expression during physiological and developmental processes are well-recognized. These roles are being expanded by recent observations that emphasize the capability of miRNA to participate in inter-cellular signaling and communication. Several factors support a functional role for miRNA as mediators of cell-to-cell signaling. miRNA are able to exist within the extracellular milieu or circulation, and their stability and integrity maintained through association with binding proteins or lipoproteins, or through encapsulation within cell-derived membrane vesicles. Furthermore, miRNA can retain functionality and regulate target gene expression following their uptake by recipient cells. In this overview, we review specific examples that will highlight the potential of miRNA to serve as paracrine signaling mediators in metabolic diseases and cancers. Elucidating the mechanisms involved in inter-cellular communication involving miRNA will provide new insights into disease pathogenesis and potential therapeutic opportunities.

AB - The contribution of microRNAs to the regulation of mRNA expression during physiological and developmental processes are well-recognized. These roles are being expanded by recent observations that emphasize the capability of miRNA to participate in inter-cellular signaling and communication. Several factors support a functional role for miRNA as mediators of cell-to-cell signaling. miRNA are able to exist within the extracellular milieu or circulation, and their stability and integrity maintained through association with binding proteins or lipoproteins, or through encapsulation within cell-derived membrane vesicles. Furthermore, miRNA can retain functionality and regulate target gene expression following their uptake by recipient cells. In this overview, we review specific examples that will highlight the potential of miRNA to serve as paracrine signaling mediators in metabolic diseases and cancers. Elucidating the mechanisms involved in inter-cellular communication involving miRNA will provide new insights into disease pathogenesis and potential therapeutic opportunities.

KW - cancer microenvironment

KW - cell–cell communication

KW - extracellular vesicles

KW - metabolic disorders

KW - miRNAs

UR - http://www.scopus.com/inward/record.url?scp=84995665353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995665353&partnerID=8YFLogxK

U2 - 10.1016/j.beem.2016.07.005

DO - 10.1016/j.beem.2016.07.005

M3 - Review article

VL - 30

SP - 577

EP - 590

JO - Best Practice and Research in Clinical Endocrinology and Metabolism

JF - Best Practice and Research in Clinical Endocrinology and Metabolism

SN - 1521-690X

IS - 5

ER -